Acomplia was designed to block cannabinoid receptors in the brain to curb cravings for food and nicotine. While it was briefly approved in Europe in 2006, it faced a rocky road in North America:
The primary reason for its withdrawal was a significant increase in . Clinical data revealed that patients taking Acomplia were roughly twice as likely to experience: Severe depression acomplia buy canada
The Truth About Acomplia: Why You Can’t (and Shouldn’t) Buy It in Canada Acomplia was designed to block cannabinoid receptors in
It is illegal to sell or distribute Acomplia (rimonabant) in Canada because it is an unauthorized health product. acomplia buy canada